186 related articles for article (PubMed ID: 25681471)
1. Antiproliferative activity of long chain acylated esters of quercetin-3-O-glucoside in hepatocellular carcinoma HepG2 cells.
Sudan S; Rupasinghe HV
Exp Biol Med (Maywood); 2015 Nov; 240(11):1452-64. PubMed ID: 25681471
[TBL] [Abstract][Full Text] [Related]
2. Quercetin-3-O-glucoside induces human DNA topoisomerase II inhibition, cell cycle arrest and apoptosis in hepatocellular carcinoma cells.
Sudan S; Rupasinghe HP
Anticancer Res; 2014 Apr; 34(4):1691-9. PubMed ID: 24692698
[TBL] [Abstract][Full Text] [Related]
3. Flavonoid-enriched apple fraction AF4 induces cell cycle arrest, DNA topoisomerase II inhibition, and apoptosis in human liver cancer HepG2 cells.
Sudan S; Rupasinghe HP
Nutr Cancer; 2014; 66(7):1237-46. PubMed ID: 25256427
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid esters of phloridzin induce apoptosis of human liver cancer cells through altered gene expression.
Nair SV; Ziaullah ; Rupasinghe HP
PLoS One; 2014; 9(9):e107149. PubMed ID: 25229655
[TBL] [Abstract][Full Text] [Related]
5. Long chain fatty acid acylated derivatives of quercetin-3-o-glucoside as antioxidants to prevent lipid oxidation.
Warnakulasuriya SN; Ziaullah ; Rupasinghe HP
Biomolecules; 2014 Nov; 4(4):980-93. PubMed ID: 25384198
[TBL] [Abstract][Full Text] [Related]
6. Long Chain Fatty Acid Esters of Quercetin-3-O-glucoside Attenuate H₂O₂-induced Acute Cytotoxicity in Human Lung Fibroblasts and Primary Hepatocytes.
Warnakulasuriya SN; Ziaullah ; Rupasinghe HP
Molecules; 2016 Apr; 21(4):452. PubMed ID: 27058521
[TBL] [Abstract][Full Text] [Related]
7. New Approach for Treatment of Primary Liver Tumors: The Role of Quercetin.
Brito AF; Ribeiro M; Abrantes AM; Mamede AC; Laranjo M; Casalta-Lopes JE; Gonçalves AC; Sarmento-Ribeiro AB; Tralhão JG; Botelho MF
Nutr Cancer; 2016; 68(2):250-66. PubMed ID: 26943884
[TBL] [Abstract][Full Text] [Related]
8. Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells.
Zhao JL; Zhao J; Jiao HJ
Appl Biochem Biotechnol; 2014 Jan; 172(2):784-91. PubMed ID: 24122665
[TBL] [Abstract][Full Text] [Related]
9. Novel carbocyclic curcumin analog CUR3d modulates genes involved in multiple apoptosis pathways in human hepatocellular carcinoma cells.
Bhullar KS; Jha A; Rupasinghe HP
Chem Biol Interact; 2015 Dec; 242():107-22. PubMed ID: 26409325
[TBL] [Abstract][Full Text] [Related]
10. Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
Nass N; Streit S; Wybranski C; Jürgens J; Brauner J; Schulz N; Powerski M; Ricke J; Kalinski T; Dudeck O; Seidensticker M
Anticancer Res; 2017 Jan; 37(1):87-93. PubMed ID: 28011478
[TBL] [Abstract][Full Text] [Related]
11. 1118-20, an indazole diarylurea compound, inhibits hepatocellular carcinoma HepG2 proliferation and tumour angiogenesis involving Wnt/β-catenin pathway and receptor tyrosine kinases.
Lu YY; Wang JJ; Zhang XK; Li WB; Guo XL
J Pharm Pharmacol; 2015 Oct; 67(10):1393-405. PubMed ID: 26076716
[TBL] [Abstract][Full Text] [Related]
12. Sequence‑dependent effect of sorafenib in combination with natural phenolic compounds on hepatic cancer cells and the possible mechanism of action.
Bahman AA; Abaza MSI; Khoushiash SI; Al-Attiyah RJ
Int J Mol Med; 2018 Sep; 42(3):1695-1715. PubMed ID: 29901131
[TBL] [Abstract][Full Text] [Related]
13. The Eltrombopag antitumor effect on hepatocellular carcinoma.
Kurokawa T; Murata S; Zheng YW; Iwasaki K; Kohno K; Fukunaga K; Ohkohchi N
Int J Oncol; 2015 Nov; 47(5):1696-702. PubMed ID: 26397763
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling.
Hsu FT; Liu YC; Chiang IT; Liu RS; Wang HE; Lin WJ; Hwang JJ
Int J Oncol; 2014 Jul; 45(1):177-88. PubMed ID: 24807012
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation.
Dong S; Kong J; Kong F; Kong J; Gao J; Ji L; Pan B; Chen L; Zheng L; Sun W
BMC Cancer; 2015 Nov; 15():939. PubMed ID: 26620566
[TBL] [Abstract][Full Text] [Related]
16. Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.
Jia H; Yang Q; Wang T; Cao Y; Jiang QY; Ma HD; Sun HW; Hou MX; Yang YP; Feng F
Biochim Biophys Acta; 2016 Jul; 1860(7):1417-30. PubMed ID: 27091611
[TBL] [Abstract][Full Text] [Related]
17. JA, a new type of polyunsaturated fatty acid isolated from Juglans mandshurica Maxim, limits the survival and induces apoptosis of heptocarcinoma cells.
Gao XL; Lin H; Zhao W; Hou YQ; Bao YL; Song ZB; Sun LG; Tian SY; Liu B; Li YX
Apoptosis; 2016 Mar; 21(3):340-50. PubMed ID: 26621097
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells.
El-Daly SM; Gouhar SA; Gamal-Eldeen AM; Abdel Hamid FF; Ashour MN; Hassan NS
Anticancer Agents Med Chem; 2019; 19(18):2197-2210. PubMed ID: 31566136
[TBL] [Abstract][Full Text] [Related]
19. Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo.
Zhang W; Liu S; Liu K; Ji B; Wang Y; Liu Y
Oncol Rep; 2014 Nov; 32(5):1913-22. PubMed ID: 25176394
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo anticancer activity evaluation of ursolic acid derivatives.
Shao JW; Dai YC; Xue JP; Wang JC; Lin FP; Guo YH
Eur J Med Chem; 2011 Jul; 46(7):2652-61. PubMed ID: 21514015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
